SAR445088

· Bioverativ, a Sanofi company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SAR445088, covering 2025-09-11 to 2025-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]